Driving Global Biopharma Forward with FDA-Approved Innovations and EU Gene Therapy Leadership.

Providing a comprehensive suite of services across the entire drug development lifecycle, this company is a global leader in the pharmaceutical support industry. With expertise in research and development, diagnostic services, active pharmaceutical ingredient manufacture, and formulation development, the firm offers essential technologies and support from clinical trials to commercial-scale manufacturing and distribution. Its commitment to client service is evident through its collaborative approach, vast industry knowledge, and relationships with leading global biopharma companies. In recent years, it has played a critical role in the approval of numerous new molecular entities by the FDA and supports a significant portion of EU-approved gene therapy products.

This privately owned organization has experienced organic growth over more than five decades, employing thousands of skilled professionals across locations in Europe, North America, and Asia. Its dedication to advancing human health is matched by robust corporate social responsibility, adhering to ethical business practices, sustainable procurement policies, and a low-risk approach to tax affairs. The company operates state-of-the-art laboratories equipped with advanced technology, designed to ensure high-quality standards are met across all analytical processes. Through continuous innovation and investment in drug safety and information services, it remains at the forefront of supporting the pharmaceutical and biotech sectors worldwide.